Live, Online CE:

Prescribing for Refractive Errors in Young Children

Wednesday, August 9, 2023
6 pm - 8 pm
via Zoom

Join us live online as Dr. Ida Chung reviews the different factors to consider when prescribing refractive errors in young children. Developmental aspects of hyperopia, astigmatism, myopia, and anisometropia will be reviewed as they relate to the management of refractive errors. Prescribing guidelines based on patient age and visual findings will be provided. Be prepared to participate in live polling of various cases.

COURSE GOALS:
1. Factors to consider when managing refractive error in young children.
2. Apply hyperopia's developmental aspects to managing refractive errors in young children.
3. Apply astigmatism's developmental aspects to managing refractive errors in young children.
4. Apply myopia's developmental aspects to managing refractive errors in young children.
5. Apply the developmental aspects of anisometropia to the management of refractive errors in young children.
6. Select appropriate prescriptions for various refractive errors

SPEAKER:
Ida Chung, OD, MSHE, FCOVD, FAAO

CE CREDITS:
2

SCHEDULE:
5:50 pm - 6:00 pm - Registration Check-In
6:00 pm - 8:00 pm - Lecture followed by Q&A

COST:
NOA Members & Students - FREE
AOA/AFOS Members - $50
Non-Members - $100


Dr. Ida Chung is a pediatric optometrist at WesternU Health Eye Care Institute in Pomona, CA. She graduated from the SUNY College of Optometry in 1993 and completed her pediatrics and binocular vision residency at the Pennsylvania College of Optometry in 1994. She obtained her fellowship from the College of Optometrists in Vision Development in 1996 and became a fellow of the American Academy of Optometry in 2001. Dr. Chung is the Associate Dean of Academic Affairs and associate professor of optometry at Western University of Health Sciences College of Optometry.
 

Real World Retina - Reno

Injectable Interventions That Improve Outcomes in nAMD and DME Management

Series Co-Chairs
Arshad M. Khanani, MD, MA,  FASRS
Reno Moderator
Managing Partner
Director of Clinical Research
Director of Fellowship
Sierra Eye Associates
Clinical Associate Professor
University of Nevada
Reno, NV

Carl D. Regillo, MD, FACS
Director, Retina Service
Wills Eye Hospital
Professor of Ophthalmology
Thomas Jefferson University
Mid Atlantic Retina
Philadelphia, PA

Agenda
6:30 pm Attendee Check-in
7:00 pm CME Dinner Meeting

- Real World nAMD Management: Case Presentations

- Real World DME Management: Case Presentations

- Question & Answer

Learning Objectives
Upon successful completion of this activity, participants should be better able to:

• Recognize the need for novel treatments and regimens that can improve visual outcomes in patients with neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME).
• Assess currently available injectable treatment options and protocols for their ability to lengthen treatment intervals and provide durability of response in patients with nAMD and DME.
• Incorporate durable injectable treatment regimens that offer enhanced efficacy and safety in patients with nAMD and DME.

Target Audience
The intended audience for this activity includes retina specialists, comprehensive ophthalmologists, and other healthcare professionals involved in managing patients with neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME).

Click Here to Register to Attend

This continuing education activity is provided by

Real World Retina Webinar

Injectable Interventions That Improve Outcomes in nAMD and DME Management

Series Co-Chairs
Arshad M. Khanani, MD, MA,  FASRS
Reno Moderator
Managing Partner
Director of Clinical Research
Director of Fellowship
Sierra Eye Associates
Clinical Associate Professor
University of Nevada
Reno, NV

Carl D. Regillo, MD, FACS
Director, Retina Service
Wills Eye Hospital
Professor of Ophthalmology
Thomas Jefferson University
Mid Atlantic Retina
Philadelphia, PA

Agenda

- Real World nAMD Management: Case Presentations

- Real World DME Management: Case Presentations

- Question & Answer

Learning Objectives
Upon successful completion of this activity, participants should be better able to:

• Recognize the need for novel treatments and regimens that can improve visual outcomes in patients with neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME).
• Assess currently available injectable treatment options and protocols for their ability to lengthen treatment intervals and provide durability of response in patients with nAMD and DME.
• Incorporate durable injectable treatment regimens that offer enhanced efficacy and safety in patients with nAMD and DME.

Target Audience
The intended audience for this activity includes retina specialists, comprehensive ophthalmologists, and other healthcare professionals involved in managing patients with neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME).

Click Here to Register to Attend

This continuing education activity is provided by